BACKGROUND: The aim was to investigate whether 2 subgroups of Hodgkin lymphoma (Epstein-Barr virus-positive and Epstein-Barr virus-negative) are associated with smoking or alcohol. METHODS: Patients with lymphoma diagnosed between age 16 and 69 years in geographically defined areas of England were recruited between 1998 and 2003. One control, matched to each lymphoma case on sex, date of birth, and area of residence, was randomly selected from population registers. Self-reported histories of tobacco and alcohol use were collected during face-to-face interviews with cases and controls. RESULTS: Compared with lifelong nonsmokers, ever-smokers were at increased risk of Hodgkin lymphoma (odds ratio =1.4; 95% confidence interval = 1.1-1.9). This excess was among current smokers, defined as smoking 2 years before diagnosis (1.7; 1.2-2.3). An increasing trend was observed with rising numbers of years smoked. Risks fell as the number of years stopped smoking increased, becoming equivalent to that of a nonsmoker 10 or more years after quitting. Associations were suggested for Epstein-Barr virus-positive Hodgkin lymphoma, but less so for Epstein-Barr negative Hodgkin lymphoma. No associations between Hodgkin lymphoma and alcohol consumption were observed. CONCLUSIONS: The association between smoking and Hodgkin lymphoma in general, and Epstein-Barr-positive Hodgkin lymphoma in particular, is consistent with previous studies. Further exploration of the relationship between Hodgkin lymphoma and smoking and of the potential mechanisms by which smoking could interact with Epstein-Barr virus status to increase Hodgkin lymphoma risk are required.
BACKGROUND: The aim was to investigate whether 2 subgroups of Hodgkin lymphoma (Epstein-Barr virus-positive and Epstein-Barr virus-negative) are associated with smoking or alcohol. METHODS:Patients with lymphoma diagnosed between age 16 and 69 years in geographically defined areas of England were recruited between 1998 and 2003. One control, matched to each lymphoma case on sex, date of birth, and area of residence, was randomly selected from population registers. Self-reported histories of tobacco and alcohol use were collected during face-to-face interviews with cases and controls. RESULTS: Compared with lifelong nonsmokers, ever-smokers were at increased risk of Hodgkin lymphoma (odds ratio =1.4; 95% confidence interval = 1.1-1.9). This excess was among current smokers, defined as smoking 2 years before diagnosis (1.7; 1.2-2.3). An increasing trend was observed with rising numbers of years smoked. Risks fell as the number of years stopped smoking increased, becoming equivalent to that of a nonsmoker 10 or more years after quitting. Associations were suggested for Epstein-Barr virus-positive Hodgkin lymphoma, but less so for Epstein-Barr negative Hodgkin lymphoma. No associations between Hodgkin lymphoma and alcohol consumption were observed. CONCLUSIONS: The association between smoking and Hodgkin lymphoma in general, and Epstein-Barr-positive Hodgkin lymphoma in particular, is consistent with previous studies. Further exploration of the relationship between Hodgkin lymphoma and smoking and of the potential mechanisms by which smoking could interact with Epstein-Barr virus status to increase Hodgkin lymphoma risk are required.
Authors: M Kamper-Jørgensen; K Rostgaard; S L Glaser; S H Zahm; W Cozen; K E Smedby; S Sanjosé; E T Chang; T Zheng; C La Vecchia; D Serraino; A Monnereau; E V Kane; L Miligi; P Vineis; J J Spinelli; J R McLaughlin; P Pahwa; J A Dosman; M Vornanen; L Foretova; M Maynadie; A Staines; N Becker; A Nieters; P Brennan; P Boffetta; P Cocco; H Hjalgrim Journal: Ann Oncol Date: 2013-06-19 Impact factor: 32.976
Authors: Alain Monnereau; Sally L Glaser; Clayton W Schupp; Karin Ekström Smedby; Silvia de Sanjosé; Eleanor Kane; Mads Melbye; Lenka Forétova; Marc Maynadié; Anthony Staines; Nikolaus Becker; Alexandra Nieters; Paul Brennan; Paolo Boffetta; Pierluigi Cocco; Ingrid Glimelius; Jacqueline Clavel; Henrik Hjalgrim; Ellen T Chang Journal: Blood Date: 2013-09-09 Impact factor: 22.113
Authors: L J Worrillow; A G Smith; K Scott; M Andersson; A J Ashcroft; G M Dores; B Glimelius; E Holowaty; G H Jackson; G L Jones; C F Lynch; G Morgan; E Pukkala; D Scott; H H Storm; P R Taylor; M Vyberg; E Willett; L B Travis; J M Allan Journal: J Med Genet Date: 2007-10-24 Impact factor: 6.318
Authors: Kevin Y Urayama; Ruth F Jarrett; Henrik Hjalgrim; Arjan Diepstra; Yoichiro Kamatani; Amelie Chabrier; Valerie Gaborieau; Anne Boland; Alexandra Nieters; Nikolaus Becker; Lenka Foretova; Yolanda Benavente; Marc Maynadié; Anthony Staines; Lesley Shield; Annette Lake; Dorothy Montgomery; Malcolm Taylor; Karin Ekström Smedby; Rose-Marie Amini; Hans-Olov Adami; Bengt Glimelius; Bjarke Feenstra; Ilja M Nolte; Lydia Visser; Gustaaf W van Imhoff; Tracy Lightfoot; Pierluigi Cocco; Lambertus Kiemeney; Sita H Vermeulen; Ivana Holcatova; Lars Vatten; Gary J Macfarlane; Peter Thomson; David I Conway; Simone Benhamou; Antonio Agudo; Claire M Healy; Kim Overvad; Anne Tjønneland; Beatrice Melin; Federico Canzian; Kay-Tee Khaw; Ruth C Travis; Petra H M Peeters; Carlos A González; José Ramón Quirós; María-José Sánchez; José María Huerta; Eva Ardanaz; Miren Dorronsoro; Françoise Clavel-Chapelon; H Bas Bueno-de-Mesquita; Elio Riboli; Eve Roman; Paolo Boffetta; Silvia de Sanjosé; Diana Zelenika; Mads Melbye; Anke van den Berg; Mark Lathrop; Paul Brennan; James D McKay Journal: J Natl Cancer Inst Date: 2012-01-27 Impact factor: 13.506
Authors: W Cozen; M N Timofeeva; D Li; A Diepstra; D Hazelett; M Delahaye-Sourdeix; C K Edlund; L Franke; K Rostgaard; D J Van Den Berg; V K Cortessis; K E Smedby; S L Glaser; H-J Westra; L L Robison; T M Mack; H Ghesquieres; A E Hwang; A Nieters; S de Sanjose; T Lightfoot; N Becker; M Maynadie; L Foretova; E Roman; Y Benavente; K A Rand; B N Nathwani; B Glimelius; A Staines; P Boffetta; B K Link; L Kiemeney; S M Ansell; S Bhatia; L C Strong; P Galan; L Vatten; T M Habermann; E J Duell; A Lake; R N Veenstra; L Visser; Y Liu; K Y Urayama; D Montgomery; V Gaborieau; L M Weiss; G Byrnes; M Lathrop; P Cocco; T Best; A D Skol; H-O Adami; M Melbye; J R Cerhan; A Gallagher; G M Taylor; S L Slager; P Brennan; G A Coetzee; D V Conti; K Onel; R F Jarrett; H Hjalgrim; A van den Berg; J D McKay Journal: Nat Commun Date: 2014-06-12 Impact factor: 14.919
Authors: Adam J Bell; Alice Gallagher; Timothy Mottram; Annette Lake; Eleanor V Kane; Tracy Lightfoot; Eve Roman; Ruth F Jarrett Journal: PLoS One Date: 2014-11-10 Impact factor: 3.240
Authors: Victor Enciso-Mora; Peter Broderick; Yussanne Ma; Ruth F Jarrett; Henrik Hjalgrim; Kari Hemminki; Anke van den Berg; Bianca Olver; Amy Lloyd; Sara E Dobbins; Tracy Lightfoot; Flora E van Leeuwen; Asta Försti; Arjan Diepstra; Annegien Broeks; Jayaram Vijayakrishnan; Lesley Shield; Annette Lake; Dorothy Montgomery; Eve Roman; Andreas Engert; Elke Pogge von Strandmann; Katrin S Reiners; Ilja M Nolte; Karin E Smedby; Hans-Olov Adami; Nicola S Russell; Bengt Glimelius; Stephen Hamilton-Dutoit; Marieke de Bruin; Lars P Ryder; Daniel Molin; Karina Meden Sorensen; Ellen T Chang; Malcolm Taylor; Rosie Cooke; Robert Hofstra; Helga Westers; Tom van Wezel; Ronald van Eijk; Alan Ashworth; Klaus Rostgaard; Mads Melbye; Anthony J Swerdlow; Richard S Houlston Journal: Nat Genet Date: 2010-10-31 Impact factor: 38.330
Authors: Deniz Bakkalci; Yumeng Jia; Joanne R Winter; Joanna Ea Lewis; Graham S Taylor; Helen R Stagg Journal: J Glob Health Date: 2020-06 Impact factor: 4.413
Authors: R Newton; S Crouch; P Ansell; J Simpson; E V Willett; A Smith; C Burton; A Jack; E Roman Journal: Br J Cancer Date: 2007-09-25 Impact factor: 7.640